US Supreme Court to scrutinize FDA denial of flavored vape products
The U.S. Supreme Court is set on Monday to hear the U.S. Food and Drug Administration's defense of the agency's refusal to let two e-cigarette companies sell flavored vape products that regulators found to pose a significant health risk to youths.
Trump, RFK Jr and FDA Commissioner
Former FDA commissioner Scott Gottlieb is raising concerns with Senate Republicans about the president-elect’s selection of ...
The FDA granted approval to nilotinib (Danziten) on November 14, 2024, for the treatment of adult patients with newly ...
The FDA has rejected Applied Therapeutics’ attempt to win approval on the strength of a failed phase 3 trial, triggering a 75% drop in the biotech’s share price. Applied said the complete response ...
Reaffirms New Drug Application (NDA) first quarter 2025 submission guidanceConfirms no additional adult clinical trials are necessary prior to NDA submission Commenced pediatric trial in the U.S. and ...
Products sold in the Northwest have been given the highest risk status, but so far no illnesses have been reported.
Given how the U.S. Supreme Court’s conservative majority is better known for limiting the authority of federal regulatory ...
Despite hotly debated biomarkers and failed or delayed confirmatory trials, the accelerated approval program has a track ...
As part of its enforcement activities, the Food and Drug Administration sends warning letters to entities under its jurisdiction. Some letters are not ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback